Introduction

Participating Members of the European Parliament

MEP Maria Da Graça Carvalho, Former Senior Advisor of Commissioner for Research, Science and Innovation

MEP Susanna Ceccardi, Committee on Foreign Affairs

MEP Tomislav Sokol, Committee on the Internal Market and Consumer Protection SANT, Subcommittee on Public Health

MEP Aldo Patriciello, Committee on Industry, Research and Energy

Programme

Welcome Opening:
MEP Maria Da Graça Carvalho, Member of the European Parliament, Former Senior Advisor of Commissioner for Research, Science and Innovation
Mart-Jan Blauwhoff, Nuclear Medicine Europe President

Introduction
Leo Cendrowicz, Moderator, Editor of the Brussels Time Magazine

“How Nuclear Medicine changed my Conditions”
Patient testimonial with his physician, Prof. Dr med. Axel Rominger, Director of Nuclear Medicine department, Inselspital, Bern

Advancements in Molecular Imaging
Dr  Antonis Kalemis, PhD., Head of Collaborations & Physics, Molecular Imaging, EMEA, Siemens Healthineers
and
Prof. Dr med. Axel Rominger, Director of Nuclear Medicine Department, Inselspital, Bern

A message by MEP Susanna Ceccardi, Committee on Foreign Affairs

Clinical Research in Nuclear Medicine and Radioligand Therapy
Dr med. Germo Gericke, Chief Medical Officer and Head of Research and Development, Ariceum, Germany

The Radioisotopes Industry facing the Challenge of Theragnostics:  Big Efforts for small Drugs”
Dr med. Jean Bonnet MBA, Head of Strategy, IRE Belgium

A message by MEP Tomislav Sokol, Committee on the Internal Market and Consumer Protection SANT, Subcommittee on Public Health

“The Needs for Patient Care and Academic Research
Prof. Dr Wim J.G. Oyen, Professor of Diagnostic Imaging & Radiotherapy (Humanitas University, Milan,I), Nuclear Medicine Physician (Rijnstate,Arnhem,NL). Chair EANM Policy & Regulatory Affairs Committee

Timely Access to Nuclear Medicine: a MUST for EU cancer patients”
Prof. Francesco De Lorenzo, President ECPC

EU Research for Patient Impact”
Dr Margarida Goulard de Medeiros, EU JRC – Head of Unit

“Radiopharmaceuticals are “special”:
Dr med. Konrade von Bremen, CEO Swan Isotopen

Closing by MEP Aldo Patriciello, Committee on Industry, Research and Energy